Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.
about
Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responsesImmunotherapy for Gastroesophageal CancerIdentification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensors.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Cholesteryl Pullulan Encapsulated TNF-α Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza VirusMaturation of dendritic cells by pullulan promotes anti-cancer effect.Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel.Immunotherapy for Esophageal Squamous Cell Carcinoma.Future directions in esophageal cancer therapy.Immunotherapy in upper GI malignancies.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationPromising immunotherapies for esophageal cancer.Emerging immunotherapy for the treatment of esophageal cancer.Polysaccharides based nanomaterials for targeted anti-cancer drug delivery.The revival of cancer vaccines - The eminent need to activate humoral immunity.Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neckClinical relevance of antigen spreading pattern induced by CHP-MAGE-A4 cancer vaccination.Translational nanoparticle engineering for cancer vaccines.Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives.Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination.Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers.NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.Immunotherapy for esophageal squamous cell carcinoma: a review
P2860
Q28068802-2EFEF035-BA84-4AE3-9A27-C277C76C148BQ28069873-24344ABD-B918-465B-AA3F-A80C8F0D4DDFQ33788685-DD1DFFD8-F5F6-4E4B-8FF4-E8ED86C8DECFQ33815087-4F5004E8-6800-4A96-9D0A-E96167DC1B0BQ36059495-84C83C30-BA37-4F37-9693-2EC4D5A16339Q37536983-BC3A77BF-4CF5-40AA-80B0-012E35D47764Q37582041-DB26E071-0462-4599-9F21-0027D16689AEQ37730966-5A4301B4-A130-4ADB-8E16-554BA0613904Q37747378-BB93ED37-B866-4EFA-90C7-43A19F57132EQ38414152-7809B54B-6344-421E-B190-C69AF9F472B0Q38634048-C4E07648-C3F0-46AF-A5AC-E96682347B83Q38736566-E57EB619-9701-4BEC-A4FC-65CD6E13B341Q38763851-34696C81-0CBC-4ADC-8FA8-D1B474E8AE02Q38794160-21832A9E-FA6F-4F1A-A101-62ECF1E8C554Q39001905-D2759131-13B8-4B26-BFF6-5C57620C5A56Q39999283-D094025C-EA16-499B-AA43-1E29EB1D6C46Q40903761-43DF4B2F-364D-45D3-B05C-91A6340E0EC5Q46720677-48B81A99-F1E0-4232-B34E-B704ECE6570BQ50044627-387BF4A8-6617-4147-9BC6-D718BB7720F6Q50324072-AD3E73FB-ED66-47FE-9F30-9384F026C9D7Q52643527-17CC02DF-8FCF-4B28-9BE8-49D88E1C1B02Q54945263-89679208-2276-4434-88E2-51E20148BA54Q56889707-445369C0-EDE2-4474-AE2E-430BB06A796A
P2860
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@ast
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@en
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan
@nl
type
label
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@ast
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@en
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan
@nl
prefLabel
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@ast
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@en
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan
@nl
P2093
P2860
P356
P1476
Dose-dependent effects of NY-E ...... of esophageal cancer patients.
@en
P2093
Eiichi Sato
Hiroaki Ikeda
Hiroshi Miyata
Hisashi Wada
Mami Ohnishi
Masaharu Osako
Naoko Imai
Naozumi Harada
Sahoko H Sugino
P2860
P2888
P356
10.1186/1479-5876-11-246
P577
2013-10-05T00:00:00Z
P5875
P6179
1038340293